Scilex Holding (SCLX) Capital Expenditures (2022 - 2026)
Scilex Holding (SCLX) posted quarterly Capital Expenditures of $200000.0 for Q1 2026, up 19900.0% on a QoQ basis from $1000.0 in Q4 2023.
Scilex Holding (SCLX) Capital Expenditures (2022 - 2026) Analysis & Trends
Scilex Holding (SCLX) has reported Capital Expenditures for 3 consecutive years, with $200000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures changed N/A year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $200000.0 (up 19900.0% YoY), while the FY2025 annual figure was $133000.0, changed N/A from the prior year.
- Capital Expenditures came in at $200000.0 for Q1 2026 at Scilex Holding, up from $1000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $200000.0 in Q1 2026, with the low at $1000.0 in Q4 2023.
- Average Capital Expenditures over 3 years is $57250.0, with a median of $14000.0 recorded in 2022.
- The largest YoY upside for Capital Expenditures was 200.0% in 2023 against a maximum downside of 200.0% in 2023.
- Year by year, Capital Expenditures stood at $7000.0 in 2022, then tumbled by 85.71% to $1000.0 in 2023, then jumped by 19900.0% to $200000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $200000.0, $1000.0, and $21000.0 for Q1 2026, Q4 2023, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 2.33 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 1.05 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 265.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -547.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 991.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 712.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 117.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 436.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -346.00 Mn |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |